Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Free Report) had its target price trimmed by Truist Financial from $28.00 to $24.00 in a research report sent to investors on Wednesday morning, MarketBeat.com reports. The brokerage currently has a hold rating on the stock. FMS has been the topic of a number of other […]